Nutrition & Health Info Sheets for Health Professionals - St. John's Wort

St. John's Wort flower

Nutrition & Health Info Sheets contain up-to-date information about nutrition, health, and food. They are provided in two different formats for consumer and professional users. These resources are produced by Dr. Rachel Scherr and her research staff. Produced by Erin Digitale, PhD, Cristy Hathaway, BS, Sheri Zidenberg-Cherr, PhD, Karrie Heneman, PhD, UC Cooperative Extension, Center for Health and Nutrition Research, Department of Nutri tion, University of California, Davis, 2007.

In recent years a significant amount of public interest in alternative medicines has focused on the use of St. John’s wort as an antidepressant. Consumers may be attracted to this product because it is available over the counter and is perceived as safe or natural (1). St. John’s wort is one of the most extensively studied herbal medications available. Research has examined its safety, mechanism of action, product purity, and efficacy in comparison with conventional antidepressants. (Only a clinical physician, however, should diagnose and treat depression.)

What is St. John’s wort?

St. John’s wort, also known by the Latin name Hypericum perforatum, is a plant with bright yellow-orange flowers. Both leaves and flowers may be incorporated into medicinal preparations (2).

Is St. John’s wort an effective antidepressent?

Clinical trials of St. John’s wort usually compare it with placebo (sugar pill) or a tricyclic antidepressant. Tricyclic antidepressants (TCAs) are synthetic antidepressants often used to treat mild to moderate depression (2).

For treatment of mild to moderate depression

Studies of patients experiencing mild to moderate clinical depression have generally concluded that short-term use of St. John’s wort is more effective than placebo, and that it is as effective as low doses of TCAs. Additionally, studies have found that short-term use of St. John’s wort produces fewer side effects than TCAs, which may result in increased patient compliance (3).

For treatment of major depression

In addition to the large number of studies investigating mild or moderate depression, a few studies have examined the efficacy of St. John’s wort in treating major depression (4). These studies have not found significant treatment effects, and researchers have therefore concluded that patients with major depression do not benefit from St. John’s wort. Synthetic antidepressants (such as selective serotonic reuptake inhibitors, or SSRIs) are significantly more effective than St. John’s wort for the treatment of major depression.

How does St. John’s wort work?

The antidepressant mechanism of St. John’s wort is not well understood. Hyperforin and hypericin are two compounds contained in this herb that are thought to have pharmacological activity. Several compounds in St. John’s wort may be acting synergistically to produce the drug’s effects, with no single compound being solely responsible for antidepressant activity (5). The antidepressant effect is thought to result from selective inhibition of serotonin, dopamine, and norepinephrine reuptake in the central nervous system (6).

Does the use of St. John’s wort produce side effects?

Newly pregnant women and those attempting to conceive should be advised to discontinue use of St. John's wort, as damage to reproductive eggs may occur with use of high dosages, and sperm motility may be inhibited in men. Pregnant women with normal hormonal mood swings, and women with a history of postnatal depression are advised to ask maternity staff about its use. No adverse events have been seen with St. John’s wort and breast-feeding; however, no long-term studies have been conducted regarding the effects the herb may have on infants (7). When used as a monotherapy, the reported incidence of side effects for St. John’s wort is lower than for synthetic antidepressants. In clinical trials, mild side effects have included headache, fatigue, gastrointestinal upset, and restlessness (3). Potentially serious side effects of St. John’s wort include photosensitivity, which is rare, and induction of manic symptoms in predisposed patients (6).

Is it safe to combine St. John’s wort with other medications?

When combined with other medications, St. John’s wort can pose serious health concerns. This is because it increases the rate of metabolism of several types of synthetic drugs. Plasma levels of a variety of drugs can be decreased as a result.

What are some of the drugs affected by St. John’s wort (SJW)?

  • Warfarin, Coumarin, Phenprocoumon

    • Purpose of affected drug(s): anticogulants
    • Adverse effects documented when combined with SJW: lowering of serum warfarin and phenprocoumon levels; reduced reponse of warfarin (8-10)
  • Oral contraceptives

    • Purpose of affected drug(s): contraceptive, regulator of menstrual cycle
    • Adverse effects documented when combined with SJW: breakthrough bleeding; (unwanted pregnancies documented) (9,12)
  • Amitriptyline, nortriptyline

    • Purpose of affected drug(s): antidepressants
    • Adverse effects documented when combined with SJW: lowering of serum amitriptyline and nortriptyline levels by 22-40 percent (8)
  • Digoxin

    • Purpose of affected drug(s): anti-arrhythmic, cardiotonic
    • Adverse effects documented when combined with SJW: lowering of serum digoxin levels (8,9)
  • Indinavir

    • Purpose of affected drug(s): HIV protease inhibitor
    • Adverse effects documented when combined with SJW: lowering of serum indinavir levels (13)
  • Cyclosporin

    • Purpose of affected drug(s): immunosuppressant (prevent rejection of organ transplants)
    • Adverse effects documented when combined with SJW: lowering of serum cyclosporin levels; acute heart transplant rejection (8,9,14)
  • SSRIs (selective serotonin reuptake inhibitors)

    • Purpose of affected drug(s): antidepressants
    • Adverse effects documented when combined with SJW: symptoms of central serotonin excess, especially in elderly patients (15)

Patients who are stabilized on treatment regimes that combine St. John’s wort with other medications should not discontinue their St. John’s wort without medical supervision, as this could cause dangerous changes in the pharmacokinetics of their other medications (11). In addition, since St. John’s wort affects a variety of enzymes and transporters involved in drug metabolism, the drugs whose metabolism could potentially be changed by St. John’s wort extends far beyond those listed in the table. Patients should consult a knowledgeable physician before combining St. John’s wort with any other medications.

Are St. John’s wort products quality-controlled?

St. John’s wort is classified as a dietary supplement under the Dietary Health Education and Supplement Act of 1994. Supplements are not subject to the same regulatory procedures as conventional drugs (16). Since St. John’s wort products are prepared from extracts of plant matter, the dose of active compounds present in each preparation is uncertain. Thus, the potency of St. John’s wort supplements varies significantly from manufacturer to manufacturer and between batches prepared by the same manufacturer (5).

What can we conclude about St. John’s wort?

In general, clinical trials have found that St. John’s wort is an effective antidepressant for persons experiencing mild to moderate depression, with an efficacy similar to tricyclic antidepressants and significantly greater than placebo. However, St. John’s wort has been found ineffective for those suffering from major depression. St. John’s wort has fewer side effects than tricyclic antidepressants, which may improve patient compliance with this antidepressant regimen. The most serious safety concerns related to the use of St. John’s wort are its ability to modify the metabolism of other medications and the lack of standardization in the levels of active compounds in St. John’s wort products, which makes accurate dosing difficult.


References:

  1. Wagner PJ, et al. Taking the edge off: Why patients choose St. John’s wort. The Journal of Family Practice; 2007; 48(8): 615-19.
  2. Pilkington K, et al. St. John’s wort for depression: Time for a different perspective? American Family Physician; 2006; 71(7): 268-281.
  3. Malatay W. St. John’s wort for drepression. American Family Physician; 71(7): American Academies of Physicians http://www.aafp.org/afp/20050401/fpin.html
  4. Shelton RC, et al. Effectiveness of St. John’s wort in major depression: A randomized controlled trial. Journal of the American Medical Association; 2001; 285(15): 1978-86.
  5. Wurglics M, et al. Batch-to-batch reproducibility of St. John’s wort preparations. Pharmacopsychiatry; 2001; 34(Supp 11): S152-S156.
  6. Ernst E. The risk-benefit profile of commonly used herbal therapies: Ginko, St. John’s wort, ginseng, Echinacea, saw palmetto, and kava. Annals of Internal Medicine; 2002; 136: 42-53.
  7. Tiran D. The use of herbs by pregnant and childbearing women: A risk-benefit assessment. Complementary Therapies in Nursing and Midwifery; 2003; 9(4): 176-181.
  8. Kasper, S. Hypercum perforatum: A review of clinical studies. Pharmacopsychiatry; 2001; 34(Supp 11): S51-S55.
  9. Ernst E. Second thoughts about the safety of St. John’s wort. Lancet; 345: 2014-5.
  10. Maurer A, et al. Interaction of St. John’s wort extract with phenprocoumon. European Journal of Clinical Pharmacology; 1999; 55: A22 (abstract).
  11. Wheatley D. Safety of St. John’s wort (Hypercum perforatum). (Letter). Lancet; 2000; 355: 575-576.
  12. Yue Q, et al. Safety of St. John’s wort (Hypercum perforatum). (Letter). Lancet; 2000; 355: 576-577.
  13. Piscitelli SC, et al. Indinavir concentrations and St. John’s wort. Lancet; 2000; 355: 547-548.
  14. Ruschitzka F, et al. Acute heart transplant rejection due to St. John’s wort. Lancet; 2000: 548-549.
  15. Martin TG. Serotonin syndrome. Annals of Emergency Medicine; 1996; 20: 520-526.
  16. Kaczka K. From herbal prozac to Mark McGwire’s tonic: How the Dietary Supplement, Health and Education Act changed the regulatory landscape for health products. Journal of Contemporary Health Law and Policy; 2000; 16: 463-499.


Production of this material was supported by a grant from the Vitamin Cases Consumer Settlement Fund, created as a result of an antitrust class action. One of the purposes of the fund is to improve the health and nutrition of California consumers.


The University of California prohibits discrimination or harassment of any person on the basis of race, color, national origin, religion, sex, gender identity, pregnancy (including childbirth, and medical conditions related to pregnancy or childbirth), physical or mental  disability, medical condition (cancer-related or genetic characteristics), ancestry, marital status, age, sexual orientation, citizenship, or service in the uniformed services (as defined by the Uniformed Services Employment and Reemployment Rights Act of 1994: service  in the uniformed services includes membership, application for membership, performance of service, application for service, or obligation for service in the uniformed services) in any of its programs or activities.

University policy also prohibits reprisal or retaliation against any person in any of its programs or activities for making a complaint of discrimination or sexual harassment or for using or participating in the investigation or resolution process of any such complaint. University policy is intended to be consistent with the provisions of applicable State and Federal laws.

Copyright © The Regents of the University of California, Davis campus, 2018. All rights reserved. Inquiries regarding this publication may be directed to cns@ucdavis.edu. The information provided in this publication is intended for general consumer understanding, and is not intended to be used for medical diagnosis or treatment, or to substitute for professional medical advice.